
Engie Aydin Kamal ALABBAS
Research InterestsMedical Biochemistry
Clinical Biochemistry
pharmacology
Immunology
Gender | FEMALE |
---|---|
Place of Work | College of Health and Medical Techniques / Kirkuk |
Position | Summer training unit officer |
Qualification | Master |
Speciality | Biochemistry |
engieaydin@ntu.edu.iq | |
Phone | 07709926448 |
Address | Kirkuk - AL-wasiti, kirkuk, kirkuk, Iraq |
Skills
Medical Biochemistry (90%)
Academic Qualification
Master
Sep 1, 2019 - Oct 7, 2021Selçuk University, Turkey, in Medical Biochemistry
Bachelor
Oct 1, 2004 - Jul 1, 2008Mosul University in Science of Chemistry
Publications
Estimating of the Levels of Some Biochemical Variables, Adipokines and Cytokines in Women with Polycystic Ovarian Syndrome
Apr 1, 2025Journal Journal of natural science , biology and Medicine
publisher Wasan Talib Abed1 *, Engie Aydin Kamal ALABBAS2 , Amira Aziz Hawass3
DOI https://doi.org/10.4103/jnsbm.JNSBM_16_1_10
Issue 1 April 2025
Volume 16
This study aims to determine the relationship between age and body mass index (BMI) in women with polycystic ovarian syndrome (PCOS) and to estimate the concentration of sex hormones (Testosterone, Follicle-Stimulating Hormone (FSH), and Luteinizing Hormone (LH)), as well as the concentration of adipokines (Adropin, Irisin, Visfatin, and Chemerin). Additionally, the study examines the association between PCOS and immune responses through the measurement of interleukins (IL-6 and IL-17). Methods: This study included 120 women, comprising 80 PCOS patients who visited Azadi Teaching Hospital from April to August 2024 and 40 healthy women as a control group. Hormonal and adipokine concentrations were measured and analyzed to identify significant differences between PCOS patients and healthy individuals. Results: The highest prevalence of PCOS was observed in the 26-35 years age group (57.5%), while the lowest prevalence was in the 15-25 years age group (13.75%). The average age of PCOS patients was 29.15±5.17 years. Regarding BMI, the highest prevalence was in the 30-35 kg/m² group (67.5%), whereas the lowest was in the 21-<25 kg/m² group (8.75%). Hormonal analysis revealed significantly lower FSH levels in PCOS patients, while Testosterone and LH levels were significantly higher compared to healthy individuals (P=0.001). Adipokine analysis indicated significantly lower levels of Adropin and significantly elevated levels of Irisin, Visfatin, and Chemerin in PCOS patients (P=0.001). Additionally, interleukin levels (IL-6 and IL-17) were significantly elevated in PCOS patients compared to healthy controls (P=0.001). Conclusion: The study highlights a strong association between PCOS and BMI, as well as alterations in sex hormone levels and adipokine concentrations. PCOS was also linked to increased immune responses, as evidenced by elevated interleukin levels. These findings suggest that metabolic and inflammatory factors play a crucial role in the pathophysiology of PCOS. Further research is recommended to explore the mechanisms underlying these associations.